FetalFirst Selected to Present at NVIDIA GTC 2026
FetalFirst has been selected to present in the NVIDIA Inception Startup Pitches session at NVIDIA GTC 2026, taking place March 16–19 in San Jose, California, showcasing our work in AI‑enabled prenatal diagnostics.
NVIDIA GTC is one of the world’s leading conferences focused on AI, accelerated computing, and applied machine learning, bringing together researchers, clinicians, startups, and technology leaders working at the frontier of innovation.
FetalFirst participates in the NVIDIA Inception program, an initiative that supports startups developing advanced AI technologies across industries including healthcare.
FetalFirst will present in the session: “NVIDIA Inception Presents: Startup Pitches.”
The session introduces emerging companies applying AI to real-world challenges and provides an opportunity to share new approaches with an audience that includes healthcare innovators, researchers, investors, and technology partners.
Session details are available in the official NVIDIA GTC catalogue.
Building a Multimodal Intelligence Platform for Prenatal Care
FetalFirst’s mission is to support families and clinicians when pregnancies become complex.
Today, information from fetal imaging, genetics, and clinical history often remains fragmented across multiple systems and is difficult to interpret under time pressure.
FetalFirst is developing an AI-enabled platform designed to bring these signals together, helping specialist teams review complex cases more efficiently while supporting clearer communication with families.
Importantly, the goal is not to replace clinical expertise, but to provide clinicians with tools that help synthesise complex information while keeping physicians firmly in control of every decision.
Collaboration Across Medicine, Research, and Technology
At NVIDIA GTC 2026, FetalFirst will share how multimodal intelligence approaches could help improve the assessment and follow-up of high-risk pregnancies.
Progress in prenatal care increasingly requires collaboration across clinical medicine, genomics, medical imaging, and artificial intelligence. Events such as GTC provide a space where clinicians, researchers, and technologists can explore how these fields can work together to improve outcomes for families.
FetalFirst is currently engaging with academic and healthcare institutions on pilot collaborations and validation studies, and welcomes conversations with clinicians, hospitals, and partners interested in advancing prenatal and neonatal care.
Connect with the FetalFirst Team
If you are attending NVIDIA GTC 2026 and would like to learn more about FetalFirst, please reach out to the team or contact us through the website.
Nina Abide is the Founder & CEO of FetalFirst, a London‑based startup focused on AI‑enabled prenatal diagnostics and support for complex pregnancies.
© 2025 NVIDIA and the NVIDIA logo are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.
© 2026 FetalFirst Ltd. All rights reserved.
